Tag: Alzheimer’s
-
Alzheimer’s Disease Hijacks Brain-Fat Communication and Metabolism
Overview: A new link between Alzheimer’s and metabolic health Alzheimer’s disease is widely known for its impact on memory and cognition, but a growing body of research is revealing deeper consequences for the body’s metabolic systems. A recent study from Houston Methodist highlights how Alzheimer’s disease may hijack the brain’s communication with fat tissue, a…
-
Nemours Neurologist Wins NIH Transformative Award to Study Hippocampal Dysfunction Across Autism, Epilepsy, and Alzheimer’s
Nemours neurologist wins prestigious NIH grant to study hippocampal dysfunction Rodney Scott, MBChB, MRCP, DipStat, PhD, Division Chief of Neurology at Nemours Children’s Health in the Delaware Valley, has been awarded a National Institutes of Health (NIH) Director’s Transformative Research Award. The $2.6 million, five-year grant will fund an ambitious project to investigate malfunctions in…
-
Nemours Neurologist Wins NIH Transformative Award to Study Hippocampal Dysfunction Across Brain Disorders
Nemours Leader Receives NIH Transformative Research Award Rodney Scott, MBChB, MRCP, DipStat, PhD, Division Chief of Neurology at Nemours Children’s Health in the Delaware Valley, has been awarded a prestigious NIH Director’s Transformative Research Award. The $2.6 million grant spans five years and targets a novel, cross-disciplinary approach to hippocampal dysfunction that may cut across…
-
Quitting Smoking in Middle Age Cuts Dementia Risk
What the study found A large, multi-country study involving 9,436 adults aged 40 and older from England, the United States and 10 other European countries found a striking cognitive benefit for those who quit smoking in middle age. Over a six-year follow-up period, quitters showed slower cognitive decline and a markedly better trajectory of memory…
-
Dementia Risk Falls to Never-Smoker Levels After Quitting Smoking in Midlife
Quitting Smoking in Midlife Can Match Never-Smokers in Dementia Risk Emerging evidence suggests that giving up smoking in middle age may dramatically protect brain health. In a study involving 9,436 adults from England, the United States and 10 other European countries, those who quit smoking in midlife experienced a cognitive trajectory that, over roughly six…
-
Digital Cognitive Test and Blood Biomarkers for Alzheimer’s
Two-step workflow could reshape Alzheimer’s detection in primary care A recent study published in Nature Medicine proposes a practical, scalable approach to diagnosing Alzheimer’s disease (AD) in everyday clinics: first confirm cognitive impairment with a brief digital tool, then use a targeted blood biomarker panel to verify amyloid pathology. This “test then blood” strategy aims…
-
Against All Odds: The Doug Whitney Story of Unexpected Alzheimer’s Resilience
Against All Odds: A Man Who Defies a Grim Genetic Forecast Doug Whitney, a 76-year-old retiree from Seattle, carries a genetic mutation historically tied to early-onset Alzheimer’s disease. Yet decades after doctors predicted a cognitive decline would begin in his 40s or 50s, he remains mentally sharp and engaged with family, friends, and science. His…
-
Against All Odds: The Seattle Man Defying Early-Onset Alzheimer’s Fate
Against All Odds: A Man Defies a Genetic Fate Doug Whitney, a 76-year-old retiree from Seattle, carries a rare genetic mutation that has historically forecast severe, early-onset Alzheimer’s disease. Yet, decades after the predicted onset, Whitney remains cognitively healthy. His story—shared with scientists and researchers who call him a “scientific unicorn”—is reshaping conversations about genetic…
-
Against All Odds: How Doug Whitney Defies Early-Onset Alzheimer’s
Against All Odds: A man who defies a genetic destiny Doug Whitney, a 76-year-old Seattle retiree, carries a rare genetic mutation long thought to guarantee early-onset Alzheimer’s. Yet, decades after the predicted onset, his cognitive health remains robust. He is a living anomaly in a family history that otherwise reads like a cautionary tale, and…
-
Neurologists Call for Proactive Primary Care in Alzheimer’s Early Detection
Survey Overview A Europe-wide survey conducted by Eli Lilly and Company surveyed 400 neurologists across France, Italy, Spain and Germany to assess how primary care teams identify and refer patients with memory complaints. The results reveal a strong push from specialists for earlier action by primary care physicians (PCPs) to detect signs of cognitive decline…